SGCA
Alpha-sarcoglycan
Also known as: A2, adhalin, ADL, DMDA2, LGMD2D, SCARMD1, SGCA_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q16586
- Gene
- SGCA
- Ensembl
- ENSG00000108823
- Chromosome
- 17
- Canonical length
- 387 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
This gene encodes a component of the dystrophin-glycoprotein complex (DGC), which is critical to the stability of muscle fiber membranes and to the linking of the actin cytoskeleton to the extracellular matrix. Its expression is thought to be restricted to striated muscle. Mutations in this gene result in type 2D autosomal recessive limb-girdle muscular dystrophy. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2008]
Canonical amino-acid sequenceUniProt
387 residues, UniProt reviewed canonical sequence.
>Q16586|SGCA
1 MAETLFWTPL LVVLLAGLGD TEAQQTTLHP LVGRVFVHTL DHETFLSLPE HVAVPPAVHI
61 TYHAHLQGHP DLPRWLRYTQ RSPHHPGFLY GSATPEDRGL QVIEVTAYNR DSFDTTRQRL
121 VLEIGDPEGP LLPYQAEFLV RSHDAEEVLP STPASRFLSA LGGLWEPGEL QLLNVTSALD
181 RGGRVPLPIE GRKEGVYIKV GSASPFSTCL KMVASPDSHA RCAQGQPPLL SCYDTLAPHF
241 RVDWCNVTLV DKSVPEPADE VPTPGDGILE HDPFFCPPTE APDRDFLVDA LVTLLVPLLV
301 ALLLTLLLAY VMCCRREGRL KRDLATSDIQ MVHHCTIHGN TEELRQMAAS REVPRPLSTL
361 PMFNVHTGER LPPRVDSAQV PLILDQHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SGCA can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.42
- Highest tissue expression
- 436 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 436 nTPM
- tongue: 203 nTPM
- blood vessel: 168 nTPM
- heart muscle: 119 nTPM
- colon: 44 nTPM
- urinary bladder: 43 nTPM
Single-cell type
- late spermatids: 1,094 nCPM
- early spermatids: 182 nCPM
- myosatellite cells: 161 nCPM
- myonuclei: 113 nCPM
- vascular smooth muscle cells: 99 nCPM
- smooth muscle cells: 88 nCPM
Immune cell
- memory B-cell: 2.9 nTPM
- naive B-cell: 2.8 nTPM
- myeloid DC: 1.5 nTPM
- non-classical monocyte: 1.4 nTPM
- intermediate monocyte: 1 nTPM
- classical monocyte: 0.4 nTPM
Brain region
- cerebellum: 2.3 nTPM
- white matter: 2 nTPM
- cerebral cortex: 1.4 nTPM
- basal ganglia: 1.3 nTPM
- thalamus: 1 nTPM
- medulla oblongata: 0.7 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SGCA.
Disease | AllUniProt
Conditions SGCA is implicated in, by any mechanism.
- Muscular dystrophy, limb-girdle, autosomal recessive 3 (LGMDR3) MIM:608099
Disease | GeneticClinVar
197 pathogenic / likely-pathogenic of 848 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Autosomal recessive limb-girdle muscular dystrophy type 2D
- Autosomal recessive limb-girdle muscular dystrophy
- Abnormality of the musculature
- Sarcoglycanopathy
- SGCA-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.79
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.68
- DepMap mean gene effect
- -0.24
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SGCA as an antibody target. Whether an autoantibody or antibody against SGCA could matter depends on whether native SGCA is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SGCA is annotated at the cell surface, where native SGCA is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SGCA as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...